Skip to main content
Premium Trial:

Request an Annual Quote

Hogan to Retire from Sigma-Aldrich, Qiagen Names VP of MDx, Casper Gets Promoted at Thermo Fisher, and More

NEW YORK (GenomeWeb News) - Sigma-Aldrich’s chief administrative officer and chief financial officer Michael Hogan plans to retire sometime this summer, after the company names his successor, Sigma-Aldrich said this week. Hogan said he is leaving the company to pursue volunteer and civic activities. The company has begun a search for his replacement.
 

 
Lynda Merrill joined Qiagen as VP of molecular diagnostics sales for Europe, Middle East, Africa, and Australia at the beginning of May, the company said this week. Merrill, who will be based in the UK, formerly was a VP at Gen-Probe and she served in management roles at Boehringer Mannheim.
 

 
Flagship Ventures’ CEO and managing partner Noubar Afeyan has received the Ellis Island Medal of Honor from the National Ethnic Coalition.
 
Afeyan serves on the board of overseers for Boston University and he is on advisory boards at the Whitehead Institute at the Massachusetts Institute of Technology and at the Harvard-MIT Division of Health Sciences and Technology. He also is on the board of directors of Helicos BioSciences.
 
Afeyan was a founder, chairman, and CEO of PerSeptive Biosystems, and was chief business officer of Applera after it acquired PerSeptive Bio .
 

 
Codon Devices has appointed Kareem Saad to the post of VP of marketing and business development, a new position at the company. Saad was CEO at Gulfstream Bioinformatics and he was GM of business development for TransMed Partners, both healthcare IT companies. Saad also held a variety of jobs at IBM, including worldwide business segment executive of R&D and as worldwide solution segment leader of clinical genomics.
 

 
David Gandara has joined Response Genetics’ board of directors. Gandara is a professor of medicine at the University of California, Davis, School of Medicine and he is director of clinical research and director of the thoracic oncology program at the UC-Davis Cancer Center. He also is a member of the board of directors at the International Association for the Study of Lung Cancer and at the Addario Foundation. He has been a director at the American Society of Clinical Oncology and he serves on professional committees at the National Cancer Institute.
 

 
Thermo Fisher Scientific has promoted Marc Casper to the post of chief operating officer, a new position at the company. Casper formerly was Thermo Fisher’s president of Analytical Technologies. He started with the company in 2001 as Life Sciences president, and he formerly was CEO and director of Kendro Laboratory Products. He also had been president of the Americas region for Dade Behring, and he was a strategy consultant at Bain & Company.
 

 
Symyx Technologies has named Trevor Heritage president of its Symyx Software business. Heritage came to Symyx in October 2007, when the company bought MDL Information Systems, where he was senior VP of the Workflow Business Group. Heritage succeeds Timothy Campbell, who is leaving the company to work for a supply chain solutions software company.
 

 
Timothy Thompson has joined Proventys as president and CEO of the firm. He formerly served as managing director of business development at Aetna. In addition, Proventys said that Marc Owen, executive vice president of corporate strategy and business development at McKesson, has joined the firm's board of directors.
 

 
Cancer therapeutics company Algeta has appointed Oystein Soug to the job of chief financial officer. Soug arrives at Algeta from his role as CFO of Orkla Foods, and he has worked in Russia and in Norway in international finance and corporate development.
 

 
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.
 

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.